Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024
Compare Balance Sheet Results of Onyx Biotec
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
18.13
33.00
-14.87
-45.06%
Share Warrants & Outstandings
Total Reserve
37.49
6.46
31.03
480.34%
Shareholder's Funds
55.62
39.46
16.16
40.95%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.76
0.38
6.38
1,678.95%
Secured Loans
5.49
0.15
5.34
3,560.00%
Unsecured Loans
1.27
0.23
1.04
452.17%
Deferred Tax Assets / Liabilities
3.14
0.33
2.81
851.52%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.13
-0.13
-100.00%
Total Non-Current Liabilities
9.90
0.84
9.06
1,078.57%
Current Liabilities
Trade Payables
16.73
17.76
-1.03
-5.80%
Other Current Liabilities
3.30
3.57
-0.27
-7.56%
Short Term Borrowings
5.70
10.21
-4.51
-44.17%
Short Term Provisions
0.00
0.08
-0.08
-100.00%
Total Current Liabilities
25.73
31.62
-5.89
-18.63%
Total Liabilities
91.25
71.91
19.34
26.89%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
40.90
10.98
29.92
272.50%
Less: Accumulated Depreciation
0.00
1.37
-1.37
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
40.90
9.61
31.29
325.60%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.17
-0.17
-100.00%
Other Non Current Assets
1.16
0.00
1.16
0.00%
Total Non-Current Assets
42.06
12.41
29.65
238.92%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
16.10
23.24
-7.14
-30.72%
Sundry Debtors
20.23
34.95
-14.72
-42.12%
Cash and Bank
8.61
0.06
8.55
14,250.00%
Other Current Assets
4.07
0.00
4.07
0.00%
Short Term Loans and Advances
0.17
1.25
-1.08
-86.40%
Total Current Assets
49.19
59.50
-10.31
-17.33%
Net Current Assets (Including Current Investments)
23.46
27.88
-4.42
-15.85%
Total Current Assets Excluding Current Investments
49.19
59.50
-10.31
-17.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
91.25
71.91
19.34
26.89%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
12.46
10.59
1.87
17.66%
Book Value per share (adjusted)
30.68
11.42
19.26
168.65%
Annual - Borrowings
Borrowings 12.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 40.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 49.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024






